IP Library Granted Patent US 12,441,761
Granted Patent B2
US 12,441,761 · App. 18/182,199 · Granted Oct 14, 2025

Conjugation reagents and methods using 1,2-cyclohexanediones

Inventors: Robert C. James (San Diego, CA); Stephen Verespy, III (San Diego, CA); Eric Cunyu Zhou (San Diego, CA); Eric Okerberg (San Diego, CA); Kelsey Rose Schramma (San Diego, CA); Fei Huang (San Diego, CA)
Assignee: Encodia, Inc.
C07K1/13C07C49/603C07D235/02C07K1/1072G01N33/582G01N33/68
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,441,761
App. No.
18/182,199
Granted
Oct 14, 2025
Kind
B2
Abstract

The present invention relates to methods to use cyclohexan-1,2-dione (CHD) groups to attach labels, linkers, and other molecules to a target compound comprising a CHD-reactive group such as a guanidine, amidine, urea, thiourea and the like. Methods of the invention include milder conditions than those previously known for promoting reaction of CHD with CHD-reactive groups, which makes the methods suitable for use with base-sensitive compounds and complex biomolecules. Methods of the invention are especially useful for attaching linking and labeling groups to a peptide that comprises at least one arginine residue, and can also be used to link such peptides to other target molecules such as nucleic acids. The invention also provides CHD-containing conjugation reagents and compositions comprising CHD-containing intermediates, and precursors useful for making CD-containing compounds that can be used in the methods of the invention.

Claims (15)

1. A composition comprising a peptide-polynucleotide conjugate, wherein a covalent linkage connecting a peptide and a polynucleotide of the peptide-polynucleotide conjugate comprises the following substructure (D):

or a tautomer thereof, wherein:

the dashed bond to Nuc represents where substructure (D) is covalently linked to the polynucleotide;

the dashed bond to Pep represents where substructure (D) is covalently linked to the peptide;

R 4 is an optional substituent on the cyclopentyl ring, and

each R 4 is independently selected from the group consisting of C 1-2 alkyl, C 1-2 alkoxy, C 1-2 haloalkyl, —COOR, SO 3 R, halo, hydroxy, and C(O)NR 2 ;

each R is independently H or C 1-4 alkyl optionally substituted with up to three groups selected from the group consisting of halo, OH, C 1-2 alkyl, C 1-2 haloalkyl, C 1-2 alkoxy, and carbonyl (oxo), or two R groups on one N are forming a 4-8 membered ring optionally containing an additional one or two heteroatoms selected from N, O and S as ring members and optionally substituted with one or two groups selected from halo, C 1-2 alkyl, C 1-2 haloalkyl, C 1-2 alkoxy, hydroxy, and carbonyl (oxo); and n is 0, 1, 2 or 3.

2. The composition of claim 1 , further comprising a solid support, wherein the peptide is attached to the solid support via a linker.

3. The composition of claim 1 , wherein the covalent linkage is attached to an arginine residue of the peptide.

4. The composition of claim 2 , wherein the peptide is covalently attached to the solid support and the linker is a cleavable linker.

5. The composition of claim 1 , wherein the covalent linkage connecting the peptide and the polynucleotide comprises substructure (D′):

6. The composition of claim 2 , wherein an N-terminal amino acid (NTAA) of the peptide forms a covalent bond with the linker.

7. The composition of claim 6 , wherein the covalent bond between the NTAA and the linker is an amide bond.

8. The composition of claim 1 , wherein the polynucleotide comprises a barcode.

9. The composition of claim 5 , wherein the covalent linkage is attached to an arginine residue of the peptide.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2026
From: ENCODIA, INC.
To: 2026 DF PEPTIDE ACQUISITION LLC
Reel/Frame 075642/0658 →
NON-RECOURSE ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2026
From: FIRST-CITIZENS BANK & TRUST COMPANY
To: DF PEPTIDE ACQUISITION LLC
Reel/Frame 074539/0609 →
SECURITY INTEREST Recorded Oct 21, 2025
From: ENCODIA, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 073175/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2023
From: JAMES, ROBERT C.; VERESPY, STEPHEN, III; ZHOU, ERIC CUNYU; OKERBERG, ERIC; SCHRAMMA, KELSEY ROSE; HUANG, FEI
To: ENCODIA, INC.
Reel/Frame 064811/0403 →
Continuity (4)
Division 17535516 · Nov 24, 2021
Continuation PCTUS2021057144 · Oct 28, 2021
Provisional Application 63108282 · Oct 30, 2020
Related Publication 20230295222A1 · Sep 21, 2023
References Cited (18)
US 6162922A · Anderson et al. · 2000 [cited by applicant]
US 6875851B1 · Travis et al. · 2005 [cited by applicant]
US 11639366B2 · James et al. · 2023 [cited by applicant]
US 20070020624A1 · Rubenfield et al. · 2007 [cited by applicant]
US 20090264300A1 · Franch et al. · 2009 [cited by applicant]
US 20160177404A1 · McKernan · 2016 [cited by applicant]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20190151448A1 · Abel et al. · 2019 [cited by applicant]
US 20200348308A1 · Chee et al. · 2020 [cited by applicant]
WO WO2020223000 · 2020 [cited by applicant]
Cotham et al., “Proteomic analysis of arginine adducts on glyoxal-modified ribonuclease,” Mol Cell Proteomics (Dec. 2004) 3(12):1145-1153. [cited by applicant]
Debets et al., “Bioorthogonal labelling of biomolecules: new functional handles and ligation methods,” Org Biomol Chem (Oct. 14, 2013) 11(38):6439-6455. [cited by applicant]
Lee et al., “Monochromophoric Design Strategy for Tetrazine-Based Colorful Bioorthogonal Probes with a Single Fluorescent Core Skeleton,” J Am Chem Soc (Jan. 24, 2018) 140(3):974-983. [cited by applicant]
Patthy et al., “Reversible modification of arginine residues. Application to sequence studies by restriction of tryptic hydrolysis to lysine residues,” J Biol Chem (Jan. 25, 1975) 250(2):557-564. [cited by applicant]
Ramil et al., “Bioorthogonal chemistry: strategies and recent developments,” Chem Commun (Camb) (Dec. 7, 2013) 49(94):11007-11022. [cited by applicant]
Wanigasekara et al., “Arginine-Selective Chemical Labeling Approach for Identification and Enrichment of Reactive Arginine Residues in Proteins,” ACS Omega (Oct. 26, 2018) 3(10):14229-14235. [cited by applicant]
Wanigasekara et al., “Evaluation of chemical labeling methods for identifying functional arginine residues of proteins by mass spectrometry,” Anal Chim Acta (Sep. 7, 2016) 935:197-206. [cited by applicant]
Wilbur et al., “Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin,” Bioconjug Chem (2002) 13(… [cited by applicant]